Wei Gai

Wei Gai

Auto-generated profile, based on publicly available information

Wei Gai

Argonne National Laboratory, Argonne, Illinois 60439

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1991 in Journal of Applied Physics
Verified
Journal Article
Closed access
WGWei Gai
Wei Gai
CHChing-Hung Ho
Ching-Hung Ho
An analytical model is given for the transverse mode suppressor of dielectric wake-field accelerators. The calculated results are compared with recent experimental data.

15 August 2001 in Journal of Applied Physics
Verified
Journal Article
Open access
PZPeng Zou
Peng Zou
LXLiling Xiao
Liling Xiao
XSXiang Sun
Xiang Sun
WGWei Gai
Wei Gai
TWThomas T. Y. Wong
Thomas T. Y. Wong
One disadvantage of conventional iris-loaded accelerating structures is the high ratio of the peak surface electric field to the peak axial electric field useful for accelerating a beam. Typically this ratio Es/Ea⩾2. The high surface electric field relative to the accelerating gradient may prove to be a limitation for realizing technologies for very high gradient accelerators. In this article, we present a scheme that uses a hybrid dielectric and iris-loaded periodic structure to reduce Es/Ea to near unity, while the shunt impedance per unit length r and the quality factor Q compare favorably with conventional metallic structures. The analysis based on MAFIA simulations of such structures shows that we can lower the peak surface electric field close to the accelerating gradient while maintaining high acceleration efficiency as measured by r/Q. Numerical examples of X-band hybrid accelerating structures are given.

3 June 2026 in bioRxiv
Verified
Preprint
Open access
ASAmalia Villagran Suarez
Amalia Villagran Suarez
KHKathryn S Hatch
Kathryn S Hatch
TBTatyana Bodrug
Tatyana Bodrug
WGWei Gai
Wei Gai
KSKatherine J Surridge
Katherine J Surridge
ALAndres E Leschziner
Andres E Leschziner
SUMMARY: Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are the second most common cause of autosomal-dominant Parkinson’s disease (PD), and increased LRRK2 kinase activity is also observed in idiopathic PD, making LRRK2 a major actionable therapeutic target. LRRK2 is a 286-kDa multidomain enzyme containing a Ras-like GTPase (ROC) and a kinase domain. Using cryo-EM, biochemical reconstitution, and cell-based assays, we show that the ROC GTPase governs switching between autoinhibited and active states: GTP binding promotes activation, whereas GDP binding enforces autoinhibition. Two common PD-linked mutations, G2019S and R1441C/G/H, activate LRRK2 through distinct structural mechanisms, revealing genotype-specific routes to dysregulation. These findings provide a unified framework for understanding LRRK2 regulation with broad therapeutic implications. Stabilizing the GDP-bound state may inhibit LRRK2 by maintaining autoinhibition, whereas promoting the GTP-bound state could be advantageous in specific cellular contexts, such as the lung, where increased LRRK2 kinase activity may play protective or regulatory roles.

1 August 2025 in Science Advances
Verified
Journal Article
Open access
WGWei Gai
Wei Gai
YWYuhang Wang
Yuhang Wang
BMBrianna Martin
Brianna Martin
Junjie ZhangJunjie Zhang
Junjie Zhang
CCChavela M. Carr
Chavela M. Carr
HRHays S. Rye
Hays S. Rye
Membrane-enclosed transport carriers return biological molecules from the recycling endosome to the plasma membrane using a mechanism that is not well understood. In Caenorhabditis elegans , the formation of carriers from the recycling endosome requires the amphiphysin protein AMPH-1. Recently, we found that purified AMPH-1 is sufficient for tubulation and vesiculation of liposomes in a mechanism that is regulated by guanine nucleotides. Here, we propose a model linking guanosine 5′-triphosphate (GTP) binding and hydrolysis to the membrane binding and tubulation required for transport carrier formation. We find that GTP binding stabilizes interactions between AMPH-1 and the membrane through amphipathic, amino-terminal α helices, which are found at the tips of the arc-shaped, homodimeric structure. By contrast, in the posthydrolysis, guanosine diphosphate–bound state, these helices are repositioned to interact with the amino-terminal helices of other homodimers, to form an oligomeric AMPH-1 lattice that tubulates the membrane, in preparation for carrier formation by membrane fission.

2 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKathryn S. Hatch
Kathryn S. Hatch
KSKatherine J. Surridge
Katherine J. Surridge
WGWei Gai
Wei Gai
BQBrookelyn Quan
Brookelyn Quan
GKGaurav Kumar
Gaurav Kumar
SRSamara L. Reck-Peterson
Samara L. Reck-Peterson
Gain-of-function of leucine-rich repeat kinase 2 (LRRK2) is a common cause of Parkinson’s disease (PD). In its autoinhibited state, the leucine-rich repeats of LRRK2 block the kinase active site, preventing substrate phosphorylation. Displacing the repeats (‘unlatching’) primes LRRK2 for activity. Preferential unlatching causes increased substrate phosphorylation of the PD allele LRRK2[R1441H], but not LRRK2[G2019S]. Here, we define a large class of PD-associated ‘unlatching’ mutations based on their effect on LRRK2 conformation. Unlatching mutants show increased localization to membranes, the site of LRRK2’s Rab substrates. Unlatching mutants are also characterized by decreased LRRK2 S935 phosphorylation, which we define as a biomarker of conformation. This framework resolves the mechanism of variants such as I2020T, which structural studies could not predict. Overall, we establish unlatching as a unifying mechanism for most PD-linked variants and describe measurable readouts for identifying LRRK2-driven disease.